Le Lézard
Classified in: Science and technology, Business
Subject: STS

Eltek 1-for-5 Reverse Stock Split of Ordinary Shares Effective as of November 22, 2017


PETAH-TIKVA, Israel, November 15, 2017 /PRNewswire/ --

Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced today that the reverse stock split previously announced by the Company on October 17, 2017, shall become effective prior to the opening of the market on November 22, 2017. Pursuant to the reverse split, each 5 Ordinary Shares, NIS 0.6 nominal value per share, will be converted into one Ordinary Share, NIS 3.00 nominal value per share. No fractional shares will be issued as a result of the reverse-split. Instead, all fractional shares will be rounded up or down to the closest whole number of shares.

As of November 15, 2017, there were 10,142,762 Ordinary Shares outstanding and after the reverse split there will be approximately 2,028,552 Ordinary Shares outstanding. The exchange agent for the reverse split is American Stock Transfer & Trust Company, whose address is 6201 15th Avenue, Brooklyn, New York 11219 (tel: (718)-921-8300).

About Eltek 

Eltek - "Innovation Across the Board", is a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), and is the Israeli leader in this industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high quality PCBs, HDI, multilayered and flex-rigid boards for the high-end market. Eltek has ITAR, AS-9100 and NADCAP Electronics permits and its customers include top of the line companies in the defense, aerospace and medical industries in Israel, the United States, Europe and Asia.

Eltek was founded in 1970. The Company's headquarters, and R&D, production and marketing center is located in Israel. Eltek operates also through its subsidiaries in North America in Europe and by agents and distributors in Europe, India, South Africa and South America.

For more information, visit Eltek's web site at http://www.nisteceltek.com.

Forward Looking Statement:  

Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to statements regarding expected results in future quarters, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company's Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission.

Investor Contact:
Amnon Shemer
Chief Financial Officer
[email protected]
+972-3-9395023

SOURCE Eltek Ltd.


These press releases may also interest you

at 22:30
Omnicom today announced the expansion of its Global Solutions Centers of Excellence with the opening of three new campus locations in Bengaluru, Chennai, and Gurugram. A fourth location will be opened in Hyderabad in October. This significant...

at 22:00
Guild of Guardians, the highly anticipated mobile RPG set to revolutionize the gaming industry, is proud to announce the upcoming launch of its epic Act 1 event, "Age of the Dread." To celebrate the first phase of the game's global release, Guild of...

at 21:53
Xiao-I Corporation ("Xiao-I" or the "Company"), a leading artificial intelligence company, is proud to announce a strategic partnership in April with a prominent Hong Kong insurance company. This collaboration aims to integrate Xiao-I's advanced AI...

at 21:09
Appvance and DMI have formed a strategic partnership to revolutionize the software quality landscape for enterprises in the public and private sectors. This partnership marks a commitment to accelerate digital transformation by harnessing the power...

at 21:00
OLED monitor display shipments significantly increased in 2023, following an upsurge of 415% year-over-year (YoY), according to Omdia's Monitor Display & OEM Market Tracker. This trend is set to continue with Omdia forecasting a 123% YoY increase in...

at 21:00
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...



News published on and distributed by: